Fineotex Chemical (FCL)₹52.79+0.53%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Fineotex Chemical reported sales of ₹378 Cr, up 175.0% from Jun 2025, and net profit of ₹48.19 Cr, up 91.9% year on year. For the year to Mar 2026, sales were ₹773 Cr and net profit ₹126 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 145 | 138 | 153 | 142 | 146 | 126 | 120 | 137 | 138 | 184 | 315 | 378 |
| Expenses | 107 | 97.58 | 115 | 107 | 109 | 91.74 | 98.68 | 112 | 107 | 148 | 269 | 316 |
| Operating Profit | 37.95 | 39.92 | 37.91 | 34.92 | 35.93 | 33.93 | 20.97 | 24.97 | 30.94 | 34.92 | 43.91 | 58.88 |
| OPM % | 26.0% | 29.0% | 25.0% | 25.0% | 25.0% | 27.0% | 18.0% | 18.0% | 23.0% | 19.0% | 14.0% | 16.0% |
| Other Income | 4.01 | 5.01 | 4.01 | 5.01 | 7.01 | 5.01 | 8.02 | 9.01 | 8.01 | 7.01 | 9.01 | 10.01 |
| Interest | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 |
| Depreciation | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 2.99 | 1.99 | 2.99 | 2.99 | 2.99 | 3.99 | 3.99 |
| Profit before tax | 39.99 | 43.97 | 39.96 | 37.96 | 40.98 | 36.01 | 26.01 | 30.98 | 34.97 | 37.97 | 47.95 | 64.92 |
| Tax % | 21.9% | 24.0% | 23.9% | 22.0% | 20.9% | 24.0% | 23.9% | 20.9% | 25.9% | 21.0% | 9.0% | 25.9% |
| Net Profit | 31.13 | 33.14 | 30.13 | 29.10 | 32.12 | 28.10 | 20.08 | 25.11 | 26.09 | 30.14 | 44.20 | 48.19 |
| EPS (Rs) | 0.27 | 0.28 | 0.26 | 0.25 | 0.27 | 0.23 | 0.16 | 0.21 | 0.22 | 0.22 | 0.26 | 0.32 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 127 | 141 | 182 | 196 | 219 | 369 | 518 | 570 | 534 | 773 | 1,015 |
| Expenses | 81.75 | 97.67 | 111 | 147 | 162 | 177 | 296 | 403 | 420 | 405 | 635 | 840 |
| Operating Profit | 27.96 | 28.96 | 29.94 | 33.93 | 34.94 | 40.94 | 70.91 | 113 | 148 | 127 | 135 | 169 |
| OPM % | 26.0% | 23.0% | 21.0% | 19.0% | 18.0% | 19.0% | 19.0% | 22.0% | 26.0% | 24.0% | 17.0% | 16.6% |
| Other Income | 2.01 | 10.02 | 5.01 | 1.01 | −11.02 | 17.01 | 6.01 | 7.01 | 17.04 | 24.05 | 33.02 | 34.04 |
| Interest | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.01 | 0.99 | 0.99 | 1.01 | 1.01 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 2.99 | 3.99 | 5.99 | 8.99 | 12.98 | 13.96 |
| Profit before tax | 28.97 | 37.98 | 33.98 | 33.97 | 21.98 | 55.98 | 72.94 | 115 | 158 | 141 | 153 | 186 |
| Tax % | 30.9% | 23.9% | 28.9% | 28.0% | 34.9% | 20.0% | 21.9% | 21.9% | 22.9% | 22.9% | 17.9% | — |
| Exceptional items | 1.01 | 0.00 | 0.00 | 0.00 | −8.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 20.08 | 29.12 | 24.08 | 24.11 | 14.05 | 45.16 | 57.20 | 90.40 | 122 | 109 | 126 | 149 |
| EPS (Rs) | 0.15 | 0.22 | 0.19 | 0.19 | 0.11 | 0.37 | 0.49 | 0.79 | 1.07 | 0.93 | 0.92 | 1.02 |
| Dividend payout % | 13.1% | 4.0% | 10.1% | 5.0% | 4.0% | 8.1% | 8.0% | 10.1% | 15.1% | 8.0% | 3.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22.05 | 22.06 | 22.06 | 22.07 | 22.06 | 22.05 | 22.05 | 22.07 | 22.07 | 22.05 | 23.05 | 116 |
| Reserves | 53.96 | 69.04 | 90.03 | 113 | 137 | 147 | 187 | 240 | 327 | 425 | 708 | 766 |
| Borrowings | 1.99 | 3.00 | 0.99 | 5.01 | 2.01 | 3.00 | 2.99 | 2.00 | 7.00 | 5.00 | 0.00 | 8.02 |
| Other Liabilities | 23.11 | 20.09 | 26.13 | 21.10 | 34.17 | 35.16 | 54.26 | 75.36 | 67.32 | 96.47 | 83.40 | 270 |
| Total Liabilities | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 340 | 424 | 549 | 816 | 1,161 |
| Fixed Assets | 17.96 | 18.95 | 26.95 | 28.92 | 35.93 | 40.92 | 58.85 | 83.87 | 98.77 | 141 | 179 | 278 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 4.99 | 0.00 | 0.00 | 0.00 | 20.98 | 1.99 |
| Investments | 29.03 | 39.09 | 47.07 | 55.11 | 48.05 | 52.09 | 32.07 | 17.03 | 89.20 | 147 | 330 | 318 |
| Other Assets | 54.12 | 56.15 | 66.19 | 77.13 | 110 | 114 | 171 | 239 | 235 | 260 | 285 | 563 |
| Inventories | 9.96 | 10.96 | 12.96 | 20.91 | 24.89 | 20.92 | 28.90 | 59.80 | 46.83 | 49.77 | 63.71 | 154 |
| Trade receivables | 22.04 | 25.05 | 29.05 | 28.05 | 49.07 | 54.08 | 83.15 | 111 | 101 | 139 | 116 | 290 |
| Cash & equivalents | 9.98 | 8.99 | 12.98 | 7.98 | 14.98 | 17.96 | 33.93 | 37.95 | 59.86 | 39.92 | 41.96 | 45.94 |
| Total Assets | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 340 | 424 | 549 | 816 | 1,161 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 14.05 | 14.06 | 19.07 | 6.02 | 12.05 | 28.11 | 9.03 | 13.06 | 107 | 97.40 | 69.29 | −24.07 |
| Cash from investing activity | −14.03 | −13.03 | −14.04 | −6.02 | 5.01 | −19.06 | −7.02 | 1.01 | −99.34 | −47.16 | −274 | 105 |
| Cash from financing activity | −2.99 | −0.99 | −5.99 | −3.99 | −2.99 | −3.99 | −3.99 | −5.99 | −5.99 | −23.96 | 176 | −62.85 |
| Net cash flow | −3.01 | −1.01 | −1.01 | −3.01 | 14.06 | 6.02 | −2.01 | 8.02 | 1.01 | 26.09 | −27.10 | 19.06 |
| Capex | 5.01 | 2.01 | 5.01 | 3.01 | 8.01 | 6.01 | 24.03 | 23.03 | 19.01 | 48.02 | 68.01 | 25.03 |
| Free cash flow | 7.99 | 11.98 | 13.98 | 3.99 | 3.99 | 21.96 | −14.98 | −8.98 | 87.87 | 48.91 | 0.99 | −48.92 |
| CFO / OP % | 109.1% | 84.1% | 104.1% | 52.1% | 63.1% | 104.1% | 46.1% | 43.1% | 119.1% | 92.1% | 77.1% | 0.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 80 | 84 | 84 | 72 | 98 | 100 | 138 | 110 | 72 | 89 | 79 | 137 |
| Inventory days | 55 | 65 | 69 | 96 | 83 | 65 | 78 | 97 | 52 | 54 | 74 | 108 |
| Days payable | 76 | 76 | 83 | 51 | 71 | 74 | 102 | 97 | 54 | 80 | 67 | 115 |
| Cash conversion cycle | 60 | 75 | 72 | 119 | 112 | 93 | 116 | 111 | 72 | 64 | 88 | 133 |
| Working capital days | 58 | 73 | 73 | 114 | 118 | 107 | 136 | 125 | 71 | 76 | 104 | 153 |
| ROCE % | 21.0% | 31.0% | 35.0% | 26.0% | 22.0% | 20.0% | 28.0% | 30.0% | 36.0% | 39.0% | 24.0% | 18.0% |
For the Jun 2026 quarter, Fineotex Chemical reported sales of ₹378 Cr, up 175.0% year on year and net profit of ₹48.19 Cr, up 91.9% year on year. The operating margin was 16.0%.
Fineotex Chemical's sales for the year to Mar 2026 were ₹773 Cr; over the last twelve months they were ₹1,015 Cr.
Net profit for the year to Mar 2026 was ₹126 Cr, and ₹149 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.02.
Fineotex Chemical reported borrowings of ₹8.02 Cr at Mar 2026, against cash and equivalents of ₹45.94 Cr.
Cash from operations was −₹24.07 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹48.92 Cr.